Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership
Go back to Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 149.22 +6.28 (4.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $142.94 | 52 Week High | $5.84 | |||
| Open | $145.61 | 52 Week Low | $5.49 | |||
| Day High | $151.85 | P/E | N/A | |||
| Day Low | $144.27 | EPS | $0.00 | |||
| Volume | 18,771,240 | |||||
